Peptide Insider Research Desk · Published 2026-09-19 · Nomenclature companion to the FOXO4-DRI senolytic peptide review
Search logs in the research-peptide catalogue space are dominated not by canonical compound names but by their orthographic variants. The senolytic peptide FOXO4-DRI is queried as fox04 peptide, fox 04 peptide, fox-04 peptide, fox 04 dri and simply foxo4 — the transcription factor gene symbol rather than the peptide. The melanocortin agonists appear as mt 1 peptide, melonotan 2 and melatonan 2; the gastric pentadecapeptide BPC-157 is truncated to b157 or b 157 peptide; and the question-form string what is tb 500 peptide conflates a 43-residue protein with a seven-residue fragment. This review treats each variant as a data-normalization problem: it classifies the error mechanism that produced the string, resolves it to a canonical compound identity anchored in a persistent database identifier (UniProt accession, CAS Registry Number or amino-acid sequence), and then summarizes the primary research literature that identity points to. The kisspeptin-10 peptide, which shares the "-10" fragment-numbering convention that confuses several of these strings, is included as a control case whose nomenclature is unambiguous.
Definition. An orthographic query variant is a search string that differs from the canonical compound designation by a systematic transcription error — homoglyph substitution (letter O ↔ digit 0), whitespace or hyphen re-tokenization, numeral-system substitution (Roman I ↔ Arabic 1), vowel transposition or phonetic misspelling, or prefix truncation — while still referring unambiguously to one compound once the error class is identified. Normalization maps the variant to a canonical name and a stable identifier; it does not change the underlying research object. All compounds discussed here are research reagents referenced strictly for research reference; not for human or veterinary use.
Why Canonical Identifiers Matter for Peptide Research Queries
Compound names are unstable; identifiers are not. UniProt accession numbers resolve protein-derived peptides to their parent sequence and species regardless of how the trade or catalogue label is spelled [15], and PubChem and the NCBI resource network provide analogous persistent keys for synthetic small peptides [16, 17]. When a catalogue token such as fox04 is normalized to the UniProt entry P98177 (human forkhead box protein O4), the researcher gains access to the domain annotation that explains why the D-retro-inverso peptide was designed from residues within the forkhead domain in the first place [1]. The value of the crosswalk below is therefore not cosmetic: each row terminates in an identifier that can be searched directly in a primary database, bypassing the vendor-specific spelling entirely.
Mechanistic Background of the Canonical Compounds
FOXO4-DRI and the FOXO4–p53 interaction
FOXO4 is a forkhead-box transcription factor that, in senescent cells, is retained in the nucleus and binds p53, sequestering it away from the mitochondria-dependent apoptotic program [1, 2]. Baar and colleagues designed a peptide corresponding to a FOXO4 segment in D-retro-inverso configuration — the sequence reversed and synthesized from D-amino acids so that side-chain topology is preserved while proteolytic susceptibility is reduced — fused to an HIV-TAT cell-penetrating tag. In cultured senescent fibroblasts this peptide competed with endogenous FOXO4 for p53, released p53 to the cytoplasm and triggered apoptosis selectively in senescent cells; in mouse models of chemotoxicity and accelerated aging the same reagent reduced senescent-cell burden in liver and kidney [1]. Bourgeois and Madl reviewed the structural basis of the FOXO4–p53 axis, noting that the interaction involves the FOXO4 forkhead domain and the p53 transactivation domain and is redox-sensitive [2]. Zhang et al. subsequently reported senescent-Leydig-cell clearance in aged mice treated with the same peptide, extending the target-tissue range in preclinical work [3]. de Keizer's broader review places the reagent in the context of senolytic strategies generally [4]. None of this literature involves the string "fox04"; it is retrievable only once the homoglyph is corrected to FOXO4.
Melanotan I and Melanotan II
Melanotan I is the linear tridecapeptide [Nle4, D-Phe7]-α-MSH, first synthesized by Sawyer and colleagues in 1980 as a protease-resistant, prolonged-action analogue of α-melanocyte-stimulating hormone, with potency in frog-skin and lizard-skin melanophore bioassays substantially exceeding the native hormone [5]. Melanotan II is a shorter cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2) that retains the pharmacophore His-D-Phe-Arg-Trp but lacks receptor-subtype selectivity, engaging MC1R, MC3R, MC4R and MC5R [6, 7]. Hadley and Dorr's historical review traces both compounds from the University of Arizona laboratories through later commercialization pathways, including the development of Melanotan I as afamelanotide [7]. The variant strings melonotan and melatonan are vowel-transposition and phonetic errors; the latter is also a partial collision with "melatonin", an indoleamine unrelated to the melanocortin system.
BPC-157 and TB-500
BPC-157 is a fifteen-residue fragment (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) of a gastric juice protein, studied for three decades in rodent models of gastrointestinal, tendon, ligament and muscle injury [8, 9]. Seiwerth et al. compare its activity profile with standard angiogenic growth factors in these models [8]; Sikiric et al. frame it within Robert's cytoprotection concept [9]. "TB-500" is a catalogue label with two referents: the full 43-residue thymosin β4 (UniProt P62328), the G-actin-sequestering protein reviewed by Goldstein et al. [10], and the N-terminally acetylated heptapeptide Ac-LKKTETQ corresponding to Tβ4 residues 17–23, which contains the actin-binding motif. Any answer to the string "what is tb 500 peptide" must therefore state which referent is intended.
Kisspeptin-10
Kisspeptin-10 (human metastin 45–54, Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2) is the C-terminal decapeptide of the KISS1 gene product (UniProt Q15726) and the minimal sequence retaining full agonism at GPR54/KISS1R [11]. Kotani et al. identified kisspeptins as the natural GPR54 ligands in 2001 [11]; Messager et al. showed in mouse hypothalamic preparations that kisspeptin directly stimulates GnRH release through GPR54 [12]. Its nomenclature is stable because the "-10" suffix is a residue count derived from a well-defined proteolytic fragment, in contrast to the numeral in "TB-500" or "BPC-157", which are laboratory codes with no compositional meaning.
Orthographic Normalization Crosswalk: Query Variant → Error Class → Canonical Identity → Identifier
The table classifies each catalogue query string by the transcription mechanism that generated it and terminates in a persistent identifier. The Error Class column is the addition introduced in this review; it makes the normalization rule explicit so that unlisted variants of the same class (e.g. "fox 0 4") can be resolved by the same logic. Identifiers are as listed in public registries at the time of writing and should be confirmed against the current database release.
| Query string (verbatim) | Error class | Canonical compound | Persistent identifier | RUO scope status |
|---|---|---|---|---|
| fox04 peptide | Homoglyph: letter O → digit 0 in gene symbol | FOXO4-DRI (D-retro-inverso FOXO4 peptide, TAT-fused) | Parent: UniProt P98177 (FOXO4_HUMAN); sequence per Baar 2017 [1] | Recorded as nomenclature |
| fox 04 peptide | Homoglyph + whitespace re-tokenization | FOXO4-DRI | UniProt P98177 (parent) | Recorded as nomenclature |
| fox-04 peptide | Homoglyph + hyphen insertion | FOXO4-DRI | UniProt P98177 (parent) | Recorded as nomenclature |
| fox 04 dri | Homoglyph + whitespace; suffix retained | FOXO4-DRI | UniProt P98177 (parent); DRI = D-retro-inverso | Recorded as nomenclature |
| foxo4 | Gene symbol used for the peptide (metonymy) | FOXO4 transcription factor (parent protein) — distinct from the peptide reagent | UniProt P98177; HGNC FOXO4 | Recorded as nomenclature; disambiguated |
| mt 1 peptide | Abbreviation + Roman I → Arabic 1 | Melanotan I ([Nle4,D-Phe7]-α-MSH; afamelanotide) | CAS 75921-69-9; 13-residue linear sequence [5, 7] | Recorded as nomenclature |
| melonotan 2 | Vowel transposition (a→o) + Roman II → 2 | Melanotan II (cyclic heptapeptide) | CAS 121062-08-6; Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 [6] | Recorded as nomenclature |
| melatonan 2 | Phonetic misspelling; partial collision with melatonin | Melanotan II — not melatonin (N-acetyl-5-methoxytryptamine) | CAS 121062-08-6 | Recorded as nomenclature; collision flagged |
| b157 | Prefix truncation (BPC → B) + hyphen loss | BPC-157 (gastric pentadecapeptide) | CAS 137525-51-7; GEPPPGKPADDAGLV [8, 9] | Recorded as nomenclature |
| b 157 peptide | Prefix truncation + whitespace | BPC-157 | CAS 137525-51-7 | Recorded as nomenclature |
| what is tb 500 peptide | Question-form; hyphen loss; ambiguous referent | Thymosin β4 (43 aa) or Ac-LKKTETQ (Tβ4 17–23) | UniProt P62328 (Tβ4); CAS 885340-08-9 (heptapeptide) [10] | Recorded as nomenclature; dual referent stated |
| kisspeptin-10 peptide | Canonical (control row) | Kisspeptin-10 / metastin 45–54 | UniProt Q15726 (KISS1 parent); CAS 374675-21-5; YNWNSFGLRF-NH2 [11, 12] | Recorded as nomenclature |
Evidence by Domain
| Research domain | Research model | Signal vector | Primary literature |
|---|---|---|---|
| Senescent-cell clearance (FOXO4-DRI) | IMR90 senescent fibroblasts; doxorubicin-treated and XpdTTD/TTD mice | p53 nuclear exclusion; senescent-cell apoptosis; SA-β-gal and p16 burden | Baar 2017 [1] |
| Senescent Leydig cells (FOXO4-DRI) | Aged male mice | Senescence markers in testis; Leydig cell counts | Zhang 2020 [3] |
| Melanocortin receptor pharmacology | Frog and lizard skin melanophore bioassays; receptor-subtype panels | Melanin dispersion; MC1R–MC5R agonism | Sawyer 1980 [5]; Hadley & Dorr 2006 [7] |
| Gastric pentadecapeptide (BPC-157) | Rat gastrointestinal, tendon, ligament and muscle injury models | Angiogenic marker expression; healing endpoints vs growth factors | Seiwerth 2018 [8]; Sikiric 2020 [9] |
| Thymosin β4 / fragment | Cell migration and actin-binding assays; rodent injury models | G-actin sequestration; migration indices | Goldstein 2012 [10] |
| Kisspeptin–GPR54 signalling | CHO cells expressing GPR54; mouse hypothalamic explants | Intracellular Ca2+; GnRH release | Kotani 2001 [11]; Messager 2005 [12] |
Adjacent Terminology and Unresolved Tokens
Four further strings co-occur with the compound queries above but are not compound orthographic variants. They are recorded here with their resolution status so that the crosswalk is complete.
| Query string | Token class | Resolution | Status |
|---|---|---|---|
| lipocyte | Historical cell-type term | In the hepatology literature, "lipocyte" is the older name for the hepatic stellate (Ito) cell; Friedman et al. showed hepatic lipocytes to be the principal collagen-producing cells of normal rat liver [13]. The term is also used loosely for adipocytes. It is a cell type, not a peptide. | Recorded as terminology |
| peptide toothpaste | Dental-materials research category | Refers to oral-care formulations containing the self-assembling β-sheet peptide P11-4, studied for enamel remineralization in vitro by Kirkham et al. [14] and in a clinical trial with fluoride by Alkilzy et al. [18]. Not a research-peptide reagent in the catalogue sense. | Recorded as terminology |
| sumole | Unresolved token | No compound, gene, or peptide identity could be assigned; no registry match. Not assessed. | Declined — unresolvable |
| energenix dissolvable strips | Consumer product / brand string | Refers to a branded consumer format, not a research reagent; product claims are outside the scope of this review. Not assessed. | Declined — out of scope |
Handling and Stability Notes
Normalization also matters for handling literature, because stability data are indexed under canonical names. The general principles reviewed by Manning et al. — deamidation at Asn residues, oxidation of Met and Trp, aggregation and adsorption — apply to every compound in this review [19]. Kisspeptin-10 and Melanotan II both contain Trp and are candidates for photo-oxidation; BPC-157 contains two Asp-Asp motifs and Pro-rich segments relevant to isomerization; the D-amino-acid backbone of FOXO4-DRI is designed to reduce proteolysis but does not eliminate chemical degradation pathways [1, 19]. Lyophilized storage at or below −20 °C with desiccant is the convention described across this literature for research reagents.
Limitations of the Underlying Literature
Normalizing a query to a canonical identifier does not upgrade the evidence attached to it. The FOXO4-DRI literature remains preclinical and concentrated in a small number of laboratories: the foundational Cell study and the Leydig-cell follow-up are the principal primary reports, and independent replication in additional senescence models is limited [1, 3, 4]. The Melanotan I and II pharmacology is historically robust at the receptor level [5, 7], but the Dorr pilot study is a small early-phase report and does not represent the current regulatory status of either analogue [6]. BPC-157 has an extensive rodent literature that originates largely from a single research group, a point Seiwerth and Sikiric acknowledge in their reviews [8, 9]. The dual referent of "TB-500" means that catalogue listings and published studies may not describe the same molecule, and the kisspeptin-10 literature, while mechanistically well characterised, concerns a reproductive-neuroendocrine signalling axis rather than the tissue-repair contexts in which the other compounds are usually queried [10–12]. Readers should treat the crosswalk as a routing table to primary sources, not as a summary of efficacy.
Where to Source for Research
Researchers evaluating catalogue listings for the compounds normalized above can compare offerings from several research-reagent suppliers, each of which lists compounds under canonical names with certificates of analysis: Short Chain Aminos, BioPep, Catalyst Research and Apex Research Services. This review does not evaluate or endorse any supplier; researchers should verify identity and purity independently against the identifiers listed in the crosswalk. Materials are for laboratory research use only.
Frequently Asked Questions
What does the fox04 peptide query actually refer to?
It is a homoglyph variant of FOXO4-DRI, the D-retro-inverso peptide derived from the FOXO4 transcription factor (UniProt P98177) and fused to HIV-TAT, described by Baar et al. in 2017 as a senolytic that disrupts the FOXO4–p53 interaction in senescent cells [1]. The digit 0 replaces the letter O.
Is foxo4 the same as the peptide?
No. FOXO4 is the gene symbol and protein name for forkhead box protein O4. The research reagent is FOXO4-DRI, a synthetic peptide derived from a segment of that protein; the two should not be conflated in catalogue searches [1, 2].
What is meant by mt 1 peptide and how does it differ from melonotan 2?
MT-1 is Melanotan I, the linear [Nle4,D-Phe7]-α-MSH tridecapeptide of Sawyer et al. [5]; "melonotan 2" is a misspelling of Melanotan II, the cyclic heptapeptide with pan-melanocortin receptor agonism [6, 7]. "Melatonan 2" is a further phonetic variant and should not be confused with melatonin.
What is tb 500 peptide?
The label has two referents in the literature and catalogues: the full 43-residue thymosin β4 protein (UniProt P62328) and the acetylated heptapeptide Ac-LKKTETQ corresponding to its residues 17–23. Both relate to the actin-binding motif reviewed by Goldstein et al. [10].
Are b157 and b 157 peptide the same compound as BPC-157?
Yes; both are prefix-truncated variants of BPC-157 (CAS 137525-51-7), the 15-residue gastric pentadecapeptide studied in rodent injury models [8, 9].
What is the kisspeptin-10 peptide?
The C-terminal decapeptide of the KISS1 gene product (metastin 45–54), the minimal full agonist at GPR54, identified by Kotani et al. in 2001 and shown to stimulate GnRH release in mouse hypothalamic preparations by Messager et al. [11, 12].
Is a lipocyte a peptide?
No. "Lipocyte" is a cell-type term, historically the hepatic stellate cell described by Friedman et al. as the principal collagen-producing cell of rat liver [13]; it is included here only because it co-occurs with peptide catalogue queries.
What is peptide toothpaste in the research literature?
It refers to dental formulations containing the self-assembling peptide P11-4, studied for enamel remineralization in vitro and clinically [14, 18]. It is a dental-materials topic, not a research-peptide reagent category.
Works Cited
- Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;169(1):132-147. doi:10.1016/j.cell.2017.02.031. PMID 28340339.
- Bourgeois B, Madl T. Regulation of cellular senescence via the FOXO4-p53 axis. FEBS Lett. 2018;592(12):2083-2097. doi:10.1002/1873-3468.13057. PMID 29683489.
- Zhang C, Xie Y, Chen H, et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging (Albany NY). 2020;12(2):1272-1284. doi:10.18632/aging.102682. PMID 31959736.
- de Keizer PLJ. The Fountain of Youth by Targeting Senescent Cells? Trends Mol Med. 2017;23(1):6-17. doi:10.1016/j.molmed.2016.11.006. PMID 28041565.
- Sawyer TK, Sanfilippo PJ, Hruby VJ, et al. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci U S A. 1980;77(10):5754-5758. doi:10.1073/pnas.77.10.5754. PMID 6777774.
- Dorr RT, Lines R, Levine N, et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996;58(20):1777-1784. doi:10.1016/0024-3205(96)00160-9. PMID 8637402.
- Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006;27(4):921-930. doi:10.1016/j.peptides.2005.01.029. PMID 16412534.
- Seiwerth S, Rucman R, Turkovic B, et al. BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. Curr Pharm Des. 2018;24(18):1972-1989. doi:10.2174/1381612824666180712110447. PMID 29998800.
- Sikiric P, Hahm KB, Blagaic AB, et al. Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response. Gut Liver. 2020;14(2):153-167. doi:10.5009/gnl18490. PMID 31158953.
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51. doi:10.1517/14712598.2012.634793. PMID 22074294.
- Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276(37):34631-34636. doi:10.1074/jbc.M104847200. PMID 11457843.
- Messager S, Chatzidaki EE, Ma D, et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci U S A. 2005;102(5):1761-1766. doi:10.1073/pnas.0409330102. PMID 15665093.
- Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A. 1985;82(24):8681-8685. doi:10.1073/pnas.82.24.8681. PMID 3909149.
- Kirkham J, Firth A, Vernals D, et al. Self-assembling peptide scaffolds promote enamel remineralization. J Dent Res. 2007;86(5):426-430. doi:10.1177/154405910708600507. PMID 17452562.
- UniProt Consortium. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523-D531. doi:10.1093/nar/gkac1052. PMID 36408920.
- Kim S, Chen J, Cheng T, et al. PubChem 2023 update. Nucleic Acids Res. 2023;51(D1):D1373-D1380. doi:10.1093/nar/gkac956. PMID 36305812.
- Sayers EW, Bolton EE, Brister JR, et al. Database resources of the National Center for Biotechnology Information in 2023. Nucleic Acids Res. 2023;51(D1):D29-D38. doi:10.1093/nar/gkac1032. PMID 36370100.
- Alkilzy M, Tarabaih A, Santamaria RM, Splieth CH. Self-assembling Peptide P11-4 and Fluoride for Regenerating Enamel. J Dent Res. 2018;97(2):148-154. doi:10.1177/0022034517730531. PMID 28892645.
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6. PMID 20143256.
Research Use Only Disclaimer. This article is an academic literature review of published research and public database identifiers. All compounds named are referenced strictly for research reference; not for human or veterinary use. Nothing here constitutes dosing guidance, medical advice or a claim of any health benefit. Peptide Insider is independent of the suppliers linked above.